Health-tech startup Ai Health Highway has raised $1 million in a pre-Series A funding round led by Turbostart. This investment is part of a larger $1.5 million funding round, which includes co-investments from notable investors such as Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation, and other angel investors.

The proceeds will be used to solidify its presence in India, accelerate international regulatory approvals, and broaden its AI/ML offerings in the cardio-respiratory domain, Ai Health Highway stated in a press release.

Founded in 2018 by Satish Jeevannavar, Ai Health Highway focuses on providing tech-enabled screening tools that aid in the early detection of non-communicable diseases (NCDs) and improve healthcare accessibility through its AI-enabled stethoscope, AiSteth. The company aims to reduce global premature deaths from NCDs by 30% by 2030.

According to Ai Health Highway, AiSteth empowers cardiac care by assisting healthcare professionals and non-specialists in interpreting heart sounds to support accurate clinical decisions. It utilizes advanced AI and signal processing to transform traditional stethoscopes into powerful screening tools capable of detecting life-threatening cardiac disorders at an early stage.

The AI-enabled stethoscope seamlessly integrates into existing workflows, equipping primary care providers with high-quality heart sound capture, analysis, and data-sharing capabilities, thereby enhancing the accessibility and affordability of healthcare solutions.

Expressing to this, Venkat Raju, Founder & CEO of Turbostart states, “We are thrilled to support Ai Health Highway and its exceptional founding team, who bring together a powerful blend of medical expertise, business acumen, and technological innovation. Their work goes beyond upgrading the stethoscope – they’re reimagining screening tools to make healthcare more accessible in the modern age. Their smart stethoscope technology has the potential to bring quality screenings to underserved communities, democratizing access to early detection. We are excited to see how they will transform healthcare accessibility, creating meaningful impact in an industry where change is not just welcome, but necessary.”

Dr. (Maj) Satish S Jeevannavar, Founder, AI Health Highway states, “We are delighted to announce Turbostart as the Lead Investor for our Pre-Series A round, joined by co-investors Rainmatter by Zerodha and BITS BioCyTiH Foundation. Our existing investors, The Chennai Angels, along with other angel investors, have also participated in this round. We are thrilled to collaborate with Turbostart on this vital mission to tackle NCDs. The expertise of their seasoned professionals and Centers of Excellence will be invaluable as we navigate the complex global healthcare landscape.”